≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Noonan syndrome

Endpoint Browser

Q17_NOONAN

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q87.14
  • Cause of death: ICD-10 — Q87.14

2 out of 7 registries used, show all original rules.

40

4. Check minimum number of events

None

40

5. Include endpoints

None

40

6. Filter based on genotype QC (FinnGen only)

40

Control definitions (FinnGen only)

Control exclude
Q17_OTHER_CONGEN_MALFO

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 40 21 19
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 14.65 24.89 3.35

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
15
18
12.73
12.35
3.6
10.3
%
125.9
147.9
0.86
15
18
(3018677) aPTT in Platelet poor plasma by Coagulation assay
23
54
8.67
10.87
3.3
13.4
s
31.7
31.6
0.03
23
54
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
14
20
10.23
9.99
3.7
14.9
g/l
2.6
3.1
0.81
14
20
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
14
26
7.75
7.90
4.9
19.4
%
89.9
91.5
0.12
14
26
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
6
13.74
4.46
2.1
5.5
%
94.7
91.3
—
7
6
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
18
70
3.86
4.09
3.4
3.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
23
106
3.75
4.06
7.1
11.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
25
125
3.67
3.84
3.4
4.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
20
87
3.60
3.80
3.8
3.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
11
33
4.22
3.49
3.0
9.8
u/l
198.3
408.7
0.61
11
33
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
16
64
3.50
3.39
3.4
6.1
mg/l
0.7
1.9
—
6
52
(3002256) Pathology report gross observation
8
18
5.27
2.97
1.3
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
31
210
3.11
2.60
18.5
7.1
ml/min/173m2
113.0
99.5
2.40
22
167
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
9
6.16
2.28
1.6
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
18
100
2.45
1.95
2.9
4.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
22
137
2.35
1.82
8.0
11.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
27
186
2.39
1.75
10.4
9.7
%
0.6
0.7
0.21
27
176
(3002030) Lymphocytes/100 leukocytes in Blood
28
198
2.38
1.68
10.3
9.3
%
24.4
34.8
5.01
28
188
(3006504) Eosinophils/100 leukocytes in Blood
27
190
2.30
1.61
10.4
9.4
%
2.9
3.1
0.21
27
176
(3042936) Bacteria identified in Isolate by Culture
9
38
2.76
1.58
3.3
2.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
27
192
2.25
1.54
10.5
9.8
%
11.0
8.2
6.08
27
182
(3044889) 12 lead EKG panel
24
163
2.18
1.53
4.3
2.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
27
194
2.21
1.47
10.5
9.1
%
59.6
51.3
3.17
27
184
(3013512) EKG study
9
42
2.47
1.45
5.0
3.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
17
104
2.10
1.39
4.2
4.4
e6/l
9.8
7.1
—
10
71
(3014576) Chloride [Moles/volume] in Serum or Plasma
8
34
2.68
1.39
2.4
10.5
mmol/l
105.8
105.1
—
8
34
(3020779) Urea [Moles/volume] in Serum or Plasma
8
39
2.31
1.24
10.0
13.6
mmol/l
4.2
5.3
—
8
39
(3002582) Erythrocytes [#/volume] in Urine
15
91
2.04
1.23
3.9
3.6
e6/l
31.3
13.9
—
10
69
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
34
0.00
1.23
0.0
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
12
67
2.13
1.21
4.3
2.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
20
2.71
1.19
1.2
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
9
45
2.28
1.15
3.0
7.4
umol/l
5.8
5.9
—
9
39
(36304419) Bacteria [Presence] in Urine
14
85
2.00
1.13
2.6
3.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
27
209
1.90
1.03
10.4
6.5
u/l
78.9
106.3
1.86
27
199
(3003694) ABO and Rh group [Type] in Blood
16
105
1.87
1.02
1.3
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
6
29
2.25
0.94
2.0
3.5
g/l
0.2
0.2
—
6
29
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
6
31
2.10
0.88
2.0
2.3
u/l
28.2
27.9
—
6
26
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
25
0.00
0.82
0.0
2.6
—
—
—
0
0
(3026782) Osmolality of Urine
9
57
1.74
0.78
4.9
2.9
mosm/kgh2o
568.7
574.4
—
9
48
(3021447) Carbon dioxide [Partial pressure] in Venous blood
9
58
1.71
0.76
5.2
11.0
kpa
6.1
5.8
—
9
58
(3022313) Gas panel - Capillary blood
8
52
1.67
0.64
29.9
9.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
40
380
+∞
0.62
35.1
17.8
e9/l
6.5
6.9
0.44
40
369
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
19
0.00
0.62
0.0
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
8
54
1.60
0.62
5.8
11.6
kpa
5.7
5.4
—
8
54
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
21
0.00
0.62
0.0
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
40
379
+∞
0.62
35.4
17.8
e9/l
244.6
269.3
0.84
40
369
(3026361) Erythrocytes [#/volume] in Blood
40
379
+∞
0.62
35.2
17.7
e12/l
4.9
4.6
3.04
40
369
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
22
0.00
0.61
0.0
1.0
—
3.4
—
0
16
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
22
0.00
0.61
0.0
1.0
—
6.8
—
0
16
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
22
0.00
0.61
0.0
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
23
0.00
0.60
0.0
1.1
—
1.5
—
0
16
(3000991) Gas panel - Venous blood
9
60
1.64
0.60
3.4
8.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
9
62
1.58
0.58
4.3
2.7
e6/l
2.2
4.7
—
9
57
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
64
1.52
0.56
20.8
14.0
mmol/l
24.2
24.6
—
9
64
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
31
336
0.66
0.56
4.4
4.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
6
40
1.59
0.54
3.2
2.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
8
57
1.50
0.46
23.4
8.9
mmol/l
23.9
24.2
—
8
57
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
5
34
1.54
0.42
2.2
2.3
iu/l
4.3
12.0
—
5
28
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
16
0.00
0.42
0.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.42
0.0
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
16
0.00
0.42
0.0
4.3
—
3.3
—
0
16
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
16
0.00
0.42
0.0
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.42
0.0
4.4
—
268.7
—
0
16
(40768804) Tissue Pathology biopsy report
12
92
1.43
0.37
1.7
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
53
1.39
0.33
1.4
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
135
0.74
0.27
1.6
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
41
1.25
0.23
2.6
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
42
1.22
0.22
2.6
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
11
0.00
0.21
0.0
6.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1.3
—
0
5
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
0.6
—
0
5
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
13
0.00
0.21
0.0
1.5
—
1.4
—
0
8
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
14
0.00
0.20
0.0
5.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
7
58
1.25
0.19
6.7
4.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
69
1.20
0.18
2.1
3.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
94
0.81
0.16
2.9
1.8
—
—
—
0
0
(3015736) pH of Urine
10
113
0.85
0.10
7.6
2.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
56
1.08
0.09
2.3
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
8
75
1.08
0.08
8.3
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
7
82
0.82
0.08
2.3
3.3
mmol/l
9.5
7.9
—
7
77
(3037467) Urinalysis macro (dipstick) panel - Urine
21
204
1.06
0.01
5.7
3.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
10
101
0.99
0.00
7.1
2.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
13
126
1.05
0.00
1.6
1.8
g/l
1.2
1.7
—
8
70
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
11.2
—
983.8
—
0
5
(3014051) Protein [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(4094501)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
28.9
—
0
9
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.8
—
1819.2
—
0
5
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
280.0
—
0
5
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
62.6
—
0
5
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
2.0
—
91.1
—
0
5
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(3028433) Virus identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
13.5
—
0
5
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1255.2
—
0
5
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
7
0.00
0.00
0.0
6.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
41.4
—
0
8
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
1.1
—
0
8
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
142.9
—
0
6
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
2.9
—
0
6
(3051611) Lipemic interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
6
65
0.91
0.00
4.2
3.0
—
1.0
—
0
6
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
88
0.89
0.00
2.3
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9
91
0.99
0.00
6.2
4.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
6
0.00
0.00
0.0
33.2
—
12.5
—
0
6
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_NOONAN – Noonan syndrome

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).